Innate Immune Protection Against HIV-1 by Reproductive Tract Epithelial Cells
生殖道上皮细胞针对 HIV-1 的先天免疫保护
基本信息
- 批准号:7891250
- 负责人:
- 金额:$ 38.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdjuvantAffectAfrican AmericanAgonistAmericanAntiviral AgentsBindingCell LineCell secretionCellsCervix UteriCollaborationsDevelopmentDiseaseEndocrineEpithelialEpithelial CellsEquilibriumEstradiolEthnic OriginExhibitsFemaleGenesGoalsGonadal Steroid HormonesGrantHIVHIV-1Host DefenseHumanHuman immunodeficiency virus testImmuneImmune responseIn VitroIncubatedInfectionLeadLearningLocal MicrobicidesMammalian OviductsMediatingMucosal Immune ResponsesNatural ImmunityPlayProductionProgesteronePropertyRaceRegulationResearchResearch PersonnelResearch Project GrantsRiskRoleSentinelSexually Transmitted DiseasesT-LymphocyteTanzaniaTestingTherapeutic InterventionTissuesUterusVaginaViralVirusWomanantimicrobialbasecaucasian Americanhuman femaleinnate immune functionknowledge basemacrophagemicrobicidepathogenpatient populationprogramsreceptorreceptor expressionreproductiveresponse
项目摘要
DESCRIPTION (provided by applicant): The overall objective of this research is to understand the role that human female reproductive tract (FRT) epithelial cells play in innate immune protection against HIV-1. As sentinels of innate immune defense, epithelial cells throughout the reproductive tract are the first line of protection against sexually transmitted infections and are crucial for orchestrating a rapid response to potential viral pathogens. Our goal in this proposal is to test the hypothesis that epithelial cells from White-American, African- American, and Tanzanian women exhibit intracellular and secreted antiviral activity that protects the reproductive tract against HIV-1. The specific aims of the current research project are to answer the following questions: 1) To what extent do epithelial cell secretions protect the female reproductive tract from HIV-1? 2) Do intracellular antiviral factors inhibit HIV-1 replication? 3) To what extent do candidate topical microbicides affect epithelial cell innate defenses? 4) Do epithelial cells influence the risk of HIV-1 infection of T cells and macrophages in the underlying stromal FRT? 5) Do FRT epithelial cells from Tanzanian women exhibit secreted and/or intracellular mechanisms of protection against HIV-1? We plan to investigate these questions using human primary epithelial cells from throughout the female reproductive tract and reproductive tract cell lines, since these cells are infectable by HIV-1, capable of protecting against HIV-1 infection, and responsive to sex hormones. The research described in this proposal will further our understanding of the mucosal immune responses involved in defending against HIV-1 and should lead to the identification of ways to augment protective responses. These studies should provide the basis of knowledge essential for the development of more effective microbicides and therapeutic interventions.
描述(由申请人提供):这项研究的总体目的是了解人类女性生殖道(FRT)上皮细胞在对HIV-1的先天免疫保护中起的作用。作为先天免疫防御的哨兵,整个生殖道的上皮细胞是针对性传播感染的第一道保护,对于策划对潜在病毒病原体的快速反应至关重要。我们在这项提案中的目标是检验以下假设:来自白人,非裔美国人和坦桑尼亚妇女的上皮细胞表现出细胞内和分泌的抗病毒活性,可保护抗HIV-1的生殖道。当前研究项目的具体目的是回答以下问题:1)上皮细胞分泌在多大程度上保护女性生殖道免受HIV-1的影响? 2)细胞内抗病毒因子是否抑制HIV-1复制? 3)候选局部菌糖在多大程度上影响上皮细胞先天防御? 4)上皮细胞是否会影响下面基质FRT中T细胞和巨噬细胞HIV-1感染的风险? 5)来自坦桑尼亚妇女的FRT上皮细胞是否表现出分泌的和/或针对HIV-1的保护的细胞内机制?我们计划使用整个女性生殖道和生殖道细胞系中的人类原发性上皮细胞研究这些问题,因为这些细胞可通过HIV-1感染,能够保护HIV-1感染,并对性激素有反应。本提案中描述的研究将进一步理解抗HIV-1涉及的粘膜免疫反应,并应导致确定增强保护性反应的方法。这些研究应为开发更有效的微生物和治疗干预措施提供知识的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles Robert Wira其他文献
Charles Robert Wira的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles Robert Wira', 18)}}的其他基金
Impact of Aging on Mucosal Immune Protection in the Female Reproductive
衰老对女性生殖粘膜免疫保护的影响
- 批准号:
10371024 - 财政年份:2019
- 资助金额:
$ 38.82万 - 项目类别:
Impact of Aging on Mucosal Immune Protection in the Female Reproductive
衰老对女性生殖粘膜免疫保护的影响
- 批准号:
10547801 - 财政年份:2019
- 资助金额:
$ 38.82万 - 项目类别:
Impact of Aging on Mucosal Immune Protection in the Female Reproductive
衰老对女性生殖粘膜免疫保护的影响
- 批准号:
10613053 - 财政年份:2019
- 资助金额:
$ 38.82万 - 项目类别:
Chemical Contraceptive Control of Microbicides in the Female Reproductive Tract
化学避孕药对女性生殖道杀菌剂的控制
- 批准号:
9210054 - 财政年份:2015
- 资助金额:
$ 38.82万 - 项目类别:
Regulation of the Reproductive Tract Environment and Prevention of HIV Infection
生殖道环境的调节与HIV感染的预防
- 批准号:
8541405 - 财政年份:2013
- 资助金额:
$ 38.82万 - 项目类别:
Menstrual Cycle Control of HIV Infection in the Reproductive Tract
月经周期控制生殖道艾滋病毒感染
- 批准号:
8624656 - 财政年份:2012
- 资助金额:
$ 38.82万 - 项目类别:
Menstrual Cycle Control of HIV Infection in the Reproductive Tract
月经周期控制生殖道艾滋病毒感染
- 批准号:
8458046 - 财政年份:2012
- 资助金额:
$ 38.82万 - 项目类别:
Menstrual Cycle Control of HIV Infection in the Reproductive Tract
月经周期控制生殖道艾滋病毒感染
- 批准号:
8317878 - 财政年份:2012
- 资助金额:
$ 38.82万 - 项目类别:
Innate Immune Protection Against HIV-1 by Reproductive Tract Epithelial Cells
生殖道上皮细胞针对 HIV-1 的先天免疫保护
- 批准号:
8856913 - 财政年份:2007
- 资助金额:
$ 38.82万 - 项目类别:
Innate Immune Protection Against HIV-1 by Reproductive Tract Epithelial Cells
生殖道上皮细胞针对 HIV-1 的先天免疫保护
- 批准号:
7658772 - 财政年份:2007
- 资助金额:
$ 38.82万 - 项目类别:
相似国自然基金
Long-TSLP和Short-TSLP佐剂对新冠重组蛋白疫苗免疫应答的影响与作用机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
Long-TSLP和Short-TSLP佐剂对新冠重组蛋白疫苗免疫应答的影响与作用机制
- 批准号:32170937
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
新疆一枝蒿多糖佐剂影响DCs调控Th1/Th2免疫应答的重要机制
- 批准号:31960164
- 批准年份:2019
- 资助金额:40 万元
- 项目类别:地区科学基金项目
草甘膦除草剂中佐剂对大豆根际土壤微生物群落的影响及其机制研究
- 批准号:31870495
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
亚细胞环境响应性的纳米材料与TLR激动剂复合制剂对疫苗免疫原性的影响
- 批准号:31600812
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Anti-flavivirus B cell response analysis to aid vaccine design
抗黄病毒 B 细胞反应分析有助于疫苗设计
- 批准号:
10636329 - 财政年份:2023
- 资助金额:
$ 38.82万 - 项目类别:
A Novel Assay to Improve Translation in Analgesic Drug Development
改善镇痛药物开发转化的新方法
- 批准号:
10726834 - 财政年份:2023
- 资助金额:
$ 38.82万 - 项目类别:
Validation of the joint-homing and drug delivery attributes of novel peptides in a mouse arthritis model
在小鼠关节炎模型中验证新型肽的关节归巢和药物递送特性
- 批准号:
10589192 - 财政年份:2023
- 资助金额:
$ 38.82万 - 项目类别:
Cellular mechanisms for the degeneration and aging of human rotator cuff tears
人类肩袖撕裂变性和衰老的细胞机制
- 批准号:
10648672 - 财政年份:2023
- 资助金额:
$ 38.82万 - 项目类别:
Intra-Articular Drug Delivery Modulating Immune Cells in Inflammatory Joint Disease
关节内药物递送调节炎症性关节疾病中的免疫细胞
- 批准号:
10856753 - 财政年份:2023
- 资助金额:
$ 38.82万 - 项目类别: